Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
54.20 AUD | -0.66% | +7.54% | +8.19% |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.61B | 2.91B | 3.61B | 3.78B | 3.94B | |||||
Total Revenues | 2.61B | 2.91B | 3.61B | 3.78B | 3.94B | |||||
Cost of Goods Sold, Total | 1.67B | 1.86B | 2.3B | 2.47B | 2.35B | |||||
Gross Profit | 936M | 1.05B | 1.31B | 1.31B | 1.59B | |||||
Selling General & Admin Expenses, Total | 416M | 390M | 461M | 494M | 602M | |||||
R&D Expenses | 32.8M | 34.3M | 38M | 39.6M | 47M | |||||
Other Operating Expenses, Total | 449M | 424M | 499M | 534M | 649M | |||||
Operating Income | 488M | 630M | 815M | 778M | 939M | |||||
Interest Expense, Total | -57.5M | -48.5M | -40.3M | -37M | -36.4M | |||||
Interest And Investment Income | 3.1M | 700K | 1M | 6.3M | 21.1M | |||||
Net Interest Expenses | -54.4M | -47.8M | -39.3M | -30.7M | -15.3M | |||||
Currency Exchange Gains (Loss) | 69.8M | -111M | 7.9M | 21.4M | 1.9M | |||||
Other Non Operating Income (Expenses) | -134M | -34.5M | -145M | -45.7M | -154M | |||||
EBT, Excl. Unusual Items | 370M | 436M | 638M | 723M | 772M | |||||
Restructuring Charges | -84.4M | -11.1M | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -2.8M | -2M | -400K | - | -20.1M | |||||
Insurance Settlements | 5.7M | 2M | 5.3M | 100K | 3.1M | |||||
Other Unusual Items | - | -13.1M | - | - | - | |||||
EBT, Incl. Unusual Items | 288M | 412M | 643M | 724M | 755M | |||||
Income Tax Expense | 46.5M | 149M | 184M | 212M | 245M | |||||
Earnings From Continuing Operations | 242M | 263M | 459M | 512M | 510M | |||||
Net Income to Company | 242M | 263M | 459M | 512M | 510M | |||||
Net Income - (IS) | 242M | 263M | 459M | 512M | 510M | |||||
Net Income to Common Incl Extra Items | 242M | 263M | 459M | 512M | 510M | |||||
Net Income to Common Excl. Extra Items | 242M | 263M | 459M | 512M | 510M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.55 | 0.59 | 1.03 | 1.15 | 1.16 | |||||
Basic EPS - Continuing Operations | 0.55 | 0.59 | 1.03 | 1.15 | 1.16 | |||||
Basic Weighted Average Shares Outstanding | 443M | 444M | 445M | 445M | 438M | |||||
Net EPS - Diluted | 0.54 | 0.59 | 1.03 | 1.15 | 1.16 | |||||
Diluted EPS - Continuing Operations | 0.54 | 0.59 | 1.03 | 1.15 | 1.16 | |||||
Diluted Weighted Average Shares Outstanding | 444M | 445M | 446M | 446M | 440M | |||||
Normalized Basic EPS | 0.52 | 0.61 | 0.9 | 1.02 | 1.1 | |||||
Normalized Diluted EPS | 0.52 | 0.61 | 0.89 | 1.01 | 1.1 | |||||
Dividend Per Share | 0.1 | - | 0.7 | - | - | |||||
Payout Ratio | 65.67 | - | 105.42 | 25.31 | - | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 619M | 765M | 976M | 951M | 1.12B | |||||
EBITA | 491M | 632M | 818M | 782M | 944M | |||||
EBIT | 488M | 630M | 815M | 778M | 939M | |||||
EBITDAR | 639M | 784M | 1B | 974M | 1.15B | |||||
Effective Tax Rate - (Ratio) | 16.15 | 36.21 | 28.61 | 29.23 | 32.41 | |||||
Current Domestic Taxes | 31.1M | 38.5M | 44.4M | 42.9M | 38.7M | |||||
Current Foreign Taxes | -39.8M | -8.6M | 53.9M | 81.4M | 133M | |||||
Total Current Taxes | -8.7M | 29.9M | 98.3M | 124M | 172M | |||||
Deferred Domestic Taxes | 4.5M | 1.4M | 9.4M | 11.8M | 17.3M | |||||
Deferred Foreign Taxes | 50.7M | 118M | 76.3M | 75.4M | 55.6M | |||||
Total Deferred Taxes | 55.2M | 119M | 85.7M | 87.2M | 72.9M | |||||
Normalized Net Income | 231M | 273M | 399M | 452M | 482M | |||||
Interest Capitalized | 9.5M | 9.5M | 1.9M | 8.5M | 19.5M | |||||
Interest on Long-Term Debt | 100K | 100K | 100K | 200K | 200K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | 53.7M | 83.1M | 111M | |||||
Selling and Marketing Expenses | - | - | - | - | - | |||||
Research And Development Expense From Footnotes | 35.8M | 37.2M | 42.1M | 41.8M | 47M | |||||
Net Rental Expense, Total | 19.5M | 19.1M | 23.3M | 23.4M | 26.9M | |||||
Imputed Operating Lease Interest Expense | 7.49M | 7.59M | 8.38M | 8.13M | 10.26M | |||||
Imputed Operating Lease Depreciation | 12.01M | 11.51M | 14.92M | 15.27M | 16.64M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 13.1M | 39.7M | 12.2M | 18.4M | 45.5M | |||||
Total Stock-Based Compensation | 13.1M | 39.7M | 12.2M | 18.4M | 45.5M |